As a conclusion, the upregulation of NONMMUT010685 and NONMMUT050689 in NAFLD downregulates XBP1 and RIPK1, increases ACYL enzyme, and causes NASH development [101]. Here, RIPK1 is linked to metabolic dysfunction-associated steatohepatitis.